Cargando…
Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective
Drug development in lupus has improved over the past 10 years but still lags behind that of other rheumatic disease areas. Assessment of prospective lupus therapies in clinical trials has proved challenging for reasons that are multifactorial including the heterogeneity of the disease, study design...
Autores principales: | Buie, Joy, Bloch, Lauren, Morand, Eric F, van Vollenhoven, Ronald F, Werth, Victoria P, Touma, Zahi, Lipsky, Peter, Kalunian, Kenneth, Askanase, Anca D, Ines, L, Reed, Christopher, Son, MaryBeth, Franson, Timothy, Costenbader, Karen, Schanberg, Laura Eve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930541/ https://www.ncbi.nlm.nih.gov/pubmed/37537705 http://dx.doi.org/10.1136/lupus-2023-000901 |
Ejemplares similares
-
The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research
por: Tse, Karin, et al.
Publicado: (2021) -
Lupus spectrum ambiguity has long-term negative implications for patients
por: Bruce, Ian N, et al.
Publicado: (2023) -
Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis
por: Werth, Victoria P., et al.
Publicado: (2021) -
Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project
por: Manzi, Susan, et al.
Publicado: (2019) -
Sex differences in rheumatoid arthritis: more than meets the eye...
por: van Vollenhoven, Ronald F
Publicado: (2009)